[go: up one dir, main page]

SE0201922D0 - Koagulationshindrande komposition (Anticoagulant Composition) - Google Patents

Koagulationshindrande komposition (Anticoagulant Composition)

Info

Publication number
SE0201922D0
SE0201922D0 SE0201922A SE0201922A SE0201922D0 SE 0201922 D0 SE0201922 D0 SE 0201922D0 SE 0201922 A SE0201922 A SE 0201922A SE 0201922 A SE0201922 A SE 0201922A SE 0201922 D0 SE0201922 D0 SE 0201922D0
Authority
SE
Sweden
Prior art keywords
tablet
composition
heparin
polar lipids
anticoagulant composition
Prior art date
Application number
SE0201922A
Other languages
English (en)
Inventor
Bengt Hersloef
Per Tingvall
Original Assignee
Ltp Lipid Technologies Provide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltp Lipid Technologies Provide filed Critical Ltp Lipid Technologies Provide
Priority to SE0201922A priority Critical patent/SE0201922D0/sv
Publication of SE0201922D0 publication Critical patent/SE0201922D0/sv
Priority to DE60315676T priority patent/DE60315676T2/de
Priority to PCT/SE2003/000973 priority patent/WO2004000332A1/en
Priority to DK03733728T priority patent/DK1542705T3/da
Priority to AT03733728T priority patent/ATE369865T1/de
Priority to PT03733728T priority patent/PT1542705E/pt
Priority to EP03733728A priority patent/EP1542705B8/en
Priority to ES03733728T priority patent/ES2291645T3/es
Priority to US10/516,858 priority patent/US7202087B2/en
Priority to AU2003239011A priority patent/AU2003239011A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
SE0201922A 2002-06-20 2002-06-20 Koagulationshindrande komposition (Anticoagulant Composition) SE0201922D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0201922A SE0201922D0 (sv) 2002-06-20 2002-06-20 Koagulationshindrande komposition (Anticoagulant Composition)
DE60315676T DE60315676T2 (de) 2002-06-20 2003-06-12 Gerinnungshemmende zusammensetzung
PCT/SE2003/000973 WO2004000332A1 (en) 2002-06-20 2003-06-12 Anticoagulant composition
DK03733728T DK1542705T3 (da) 2002-06-20 2003-06-12 Antikoagulerende sammensætning
AT03733728T ATE369865T1 (de) 2002-06-20 2003-06-12 Gerinnungshemmende zusammensetzung
PT03733728T PT1542705E (pt) 2002-06-20 2003-06-12 Ciclo-hexil(alquil)-propanolaminas, sua preparação e composições farmacêuticas que as contêm
EP03733728A EP1542705B8 (en) 2002-06-20 2003-06-12 Anticoagulant composition
ES03733728T ES2291645T3 (es) 2002-06-20 2003-06-12 Composicion anticoagulante.
US10/516,858 US7202087B2 (en) 2002-06-20 2003-06-12 Anticoagulant composition
AU2003239011A AU2003239011A1 (en) 2002-06-20 2003-06-12 Anticoagulant composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201922A SE0201922D0 (sv) 2002-06-20 2002-06-20 Koagulationshindrande komposition (Anticoagulant Composition)

Publications (1)

Publication Number Publication Date
SE0201922D0 true SE0201922D0 (sv) 2002-06-20

Family

ID=20288280

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201922A SE0201922D0 (sv) 2002-06-20 2002-06-20 Koagulationshindrande komposition (Anticoagulant Composition)

Country Status (10)

Country Link
US (1) US7202087B2 (sv)
EP (1) EP1542705B8 (sv)
AT (1) ATE369865T1 (sv)
AU (1) AU2003239011A1 (sv)
DE (1) DE60315676T2 (sv)
DK (1) DK1542705T3 (sv)
ES (1) ES2291645T3 (sv)
PT (1) PT1542705E (sv)
SE (1) SE0201922D0 (sv)
WO (1) WO2004000332A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10456327B2 (en) 2015-08-28 2019-10-29 Craig Robertson Package for frozen nutrient pill
WO2018185302A1 (en) * 2017-04-07 2018-10-11 Syddansk Universitet Moulding and casting of composites

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
AU645003B2 (en) * 1988-11-08 1994-01-06 Takeda Chemical Industries Ltd. Sustained release preparations
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
CA2182577C (en) * 1994-02-04 2002-08-20 Anders Carlsson Lipophilic carrier preparations
GB9719182D0 (en) * 1997-09-09 1997-11-12 Boc Group Plc Guide wire introducer
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
DE10026699A1 (de) * 2000-05-30 2001-12-06 Basf Ag Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage
BRPI0116121B8 (pt) * 2000-12-14 2021-05-25 F Hoffmannn La Roche Ag composição de matriz de lipídeo auto-emulsificante para administração oral e seu processo de preparação
ITMI20012599A1 (it) * 2001-12-11 2003-06-11 Cosmo Spa Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning

Also Published As

Publication number Publication date
ATE369865T1 (de) 2007-09-15
DE60315676D1 (de) 2007-09-27
EP1542705B8 (en) 2007-10-10
US20060165780A1 (en) 2006-07-27
AU2003239011A1 (en) 2004-01-06
EP1542705B1 (en) 2007-08-15
EP1542705A1 (en) 2005-06-22
ES2291645T3 (es) 2008-03-01
DK1542705T3 (da) 2007-11-26
PT1542705E (pt) 2007-11-09
WO2004000332A1 (en) 2003-12-31
US7202087B2 (en) 2007-04-10
DE60315676T2 (de) 2008-06-05

Similar Documents

Publication Publication Date Title
DK1576970T3 (da) Intraluminal indretning med en coating, der indeholder et terapeutisk middel
JO2481B1 (en) Silo cano-indol compounds have fluoride substitution and formulations containing such compounds and their treatment methods
NZ319090A (en) (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
ES2192213T3 (es) Arilalquil-diazinonas como inhibidores de fosfodiesterasa iv.
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
ES2059377T3 (es) Pirazoles 1,5-diaril-3-sustituidos farmacologicamente activos y procedimiento para sintetizar los mismos.
YU97902A (sh) Ciklopentanoindoli, smeše koje sadrže takva jedinjenja i metodi lečenja
BR9811099A (pt) Inibidores de urocinase
GB9715894D0 (en) Heterocyclic derivatives
ES2191070T3 (es) Arilalquil-piridazinonas.
MXPA05012570A (es) Derivados de tetrahidroisoquinolina como activadores de ppar-a.
PT1082321E (pt) Derivados heterociclicos que inibem o factor xa
EP1178796A4 (en) AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE
WO2003059875A3 (en) DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION
ECSP055844A (es) Nuevos compuestos triciclicos
AU3620799A (en) Heterocyclic derivatives which inhibit factor xa
DE60327511D1 (de) Zusammensetzung zur oralen oder rektalen verabreichung
SE0201922D0 (sv) Koagulationshindrande komposition (Anticoagulant Composition)
ATE488226T1 (de) Mahonia aquifolium extrakt, extraktionsverfahren und diesen enthaltende pharmazeutische zusammensetzung
HRP20050741A2 (en) 1,3-substituted cycloalkyl containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments
IL165808A0 (en) Low molecular weight k5-n,o-oversulfated polysaccharide process for the preparation thereof and pharmaceutical compositions containing the same
EA199700243A1 (ru) Производное аминотетралина для лечения сердечно-сосудистых заболеваний
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
DE602005010256D1 (de) Produkt pflanzlichen ursprungs, das proanthocyane enthält, sowie verfahren zu seiner herstellung
DE50105577D1 (de) Ribavirin-granulat zur herstellung von filmtabletten